January 11, 2000Eli Lilly and Co. Recalls
Kefurox and Mandol Injections
Indianapolis, IN (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Eli Lilly and Company is recalling Kefurox(r),
Cefuroxime for Injection and Mandol(r), Cefamandole Nafate for Injection because of lack
of assurance of sterility.
The Kefurox(r), USP, 1.5 g, a
prescription broad spectrum antibiotic with NDC #0002-7272-10 bears the lot number of
The Mandol(r), USP, 1 g, a
prescription broad spectrum antibiotic with NDC #0002-7061-25 bears the lot number of
According to FDA, 73,955 vials were
distributed nationwide and in Santo Domingo.
This ongoing Class II recall
was initiated by Eli Lilly and Company by fax, mail and United Parcel Service on October
22, 1999. This is the first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.